Caldwell Sutter Capital’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Caldwell Sutter Capital’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,458	Closed	–	–	939
2024 Q2	$0	Buy	+7,458	New	+$111K	﹤0.01%	952

Caldwell Sutter Capital's MACK Position: Q3 2024 in Review

Caldwell Sutter Capital sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2024, closing a stake of 7,458 shares.

Caldwell Sutter Capital first reported a position in MACK in Q2 2024 and held it in 1 quarter. The position peaked at $0 in Q2 2024. 2 funds tracked by Wall St. Rank hold MACK as of Q3 2024.

Caldwell Sutter Capital reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2024 after selling out during the quarter.
Caldwell Sutter Capital sold 7,458 Merrimack Pharmaceuticals, Inc. shares in Q3 2024.
Caldwell Sutter Capital first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2024 and held it in 1 quarter.
Caldwell Sutter Capital's Merrimack Pharmaceuticals, Inc. position peaked at $0 in Q2 2024.
2 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2024.

Based on Caldwell Sutter Capital's 13F filing for Q3 2024, filed 25 Oct 2024.